These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32648354)

  • 1. Paternal gender specificity and mild phenotypes in Charcot-Marie-Tooth type 1A patients with de novo 17p12 rearrangements.
    Lee AJ; Nam DE; Choi YJ; Noh SW; Nam SH; Lee HJ; Kim SJ; Song GJ; Choi BO; Chung KW
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1380. PubMed ID: 32648354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charcot-Marie-Tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP): reliable detection of the CMT1A duplication and HNPP deletion using 8 microsatellite markers in 2 multiplex PCRs.
    Seeman P; Mazanec R; Zidar J; Hrusáková S; Ctvrtecková M; Rautenstrauss B
    Int J Mol Med; 2000 Oct; 6(4):421-6. PubMed ID: 10998431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe phenotypes in a Charcot-Marie-Tooth 1A patient with PMP22 triplication.
    Kim SM; Lee J; Yoon BR; Kim YJ; Choi BO; Chung KW
    J Hum Genet; 2015 Feb; 60(2):103-6. PubMed ID: 25500726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine mapping of de novo CMT1A and HNPP rearrangements within CMT1A-REPs evidences two distinct sex-dependent mechanisms and candidate sequences involved in recombination.
    Lopes J; Ravisé N; Vandenberghe A; Palau F; Ionasescu V; Mayer M; Lévy N; Wood N; Tachi N; Bouche P; Latour P; Ruberg M; Brice A; LeGuern E
    Hum Mol Genet; 1998 Jan; 7(1):141-8. PubMed ID: 9384615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic epidemiology, demographic, and clinical characteristics of Charcot-Marie-tooth disease in the island of Gran Canaria (Spain).
    Lousa M; Vázquez-Huarte-Mendicoa C; Gutiérrez AJ; Saavedra P; Navarro B; Tugores A
    J Peripher Nerv Syst; 2019 Mar; 24(1):131-138. PubMed ID: 30569560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: new tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A. French CMT Collaborative Research Group.
    Lopes J; LeGuern E; Gouider R; Tardieu S; Abbas N; Birouk N; Gugenheim M; Bouche P; Agid Y; Brice A
    Am J Hum Genet; 1996 Jun; 58(6):1223-30. PubMed ID: 8651299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: first report of a de novo duplication with a maternal origin.
    Blair IP; Nash J; Gordon MJ; Nicholson GA
    Am J Hum Genet; 1996 Mar; 58(3):472-6. PubMed ID: 8644705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease.
    Mathis S; Corcia P; Tazir M; Camu W; Magdelaine C; Latour P; Biberon J; Guennoc AM; Richard L; Magy L; Funalot B; Vallat JM
    Neuromuscul Disord; 2014 Jun; 24(6):524-8. PubMed ID: 24792522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCR-based strategy for the diagnosis of hereditary neuropathy with liability to pressure palsies and Charcot-Marie-Tooth disease type 1A.
    Young P; Stögbauer F; Wiebusch H; Löfgren A; Timmerman V; Van Broeckhoven C; Ringelstein EB; Assmann G; Funke H
    Neurology; 1998 Mar; 50(3):760-3. PubMed ID: 9521270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: unequal nonsister chromatid exchange during spermatogenesis.
    Palau F; Löfgren A; De Jonghe P; Bort S; Nelis E; Sevilla T; Martin JJ; Vilchez J; Prieto F; Van Broeckhoven C
    Hum Mol Genet; 1993 Dec; 2(12):2031-5. PubMed ID: 8111370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies: detection of the recombination in Slovene patients and exclusion of the potentially recessive Thr118Met PMP22 point mutation.
    Leonardis L; Zidar J; Ekici A; Peterlin B; Rautenstrauss B
    Int J Mol Med; 1998 Feb; 1(2):495-501. PubMed ID: 9852256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes.
    Inoue K; Dewar K; Katsanis N; Reiter LT; Lander ES; Devon KL; Wyman DW; Lupski JR; Birren B
    Genome Res; 2001 Jun; 11(6):1018-33. PubMed ID: 11381029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in hereditary neuropathy with liability to pressure palsies is as impaired as in Charcot-Marie-Tooth disease type 1A.
    Bjelica B; Peric S; Bozovic I; Jankovic M; Brankovic M; Palibrk A; Rakocevic Stojanovic V
    Acta Neurol Belg; 2021 Dec; 121(6):1481-1486. PubMed ID: 32335868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous DNA exchanges in humans can be explained by the yeast double-strand break repair model: a study of 17p11.2 rearrangements associated with CMT1A and HNPP.
    Lopes J; Tardieu S; Silander K; Blair I; Vandenberghe A; Palau F; Ruberg M; Brice A; LeGuern E
    Hum Mol Genet; 1999 Nov; 8(12):2285-92. PubMed ID: 10545609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of real-time quantitative PCR compare to repeat PCR for the diagnosis of Charcot-Marie-Tooth Type 1A and hereditary neuropathy with liability to pressure palsies.
    Choi JR; Lee WH; Sunwoo IN; Lee EK; Lee CH; Lim JB
    Yonsei Med J; 2005 Jun; 46(3):347-52. PubMed ID: 15988805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of hereditary neuropathy with liability to pressure palsies.
    Chance PF
    Ann N Y Acad Sci; 1999 Sep; 883():14-21. PubMed ID: 10586225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP).
    Timmerman V; Löfgren A; Le Guern E; Liang P; De Jonghe P; Martin JJ; Verhalle D; Robberecht W; Gouider R; Brice A; Van Broeckhoven C
    Hum Genet; 1996 Jan; 97(1):26-34. PubMed ID: 8557256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A de novo case of hereditary neuropathy with liability to pressure palsies (HNPP) of maternal origin: a new mechanism for deletion in 17p11.2?
    LeGuern E; Gouider R; Ravisé N; Lopes J; Tardieu S; Gugenheim M; Abbas N; Bouche P; Agid Y; Brice A
    Hum Mol Genet; 1996 Jan; 5(1):103-6. PubMed ID: 8789446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular genetic diagnosis of Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies].
    Aarskog NK; Vedeler CA
    Tidsskr Nor Laegeforen; 2002 Feb; 122(4):382-5. PubMed ID: 11915667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.